These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3485774)

  • 21. Changes in the activities of hepatic drug metabolizing enzymes and lipid peroxidation caused by benzene and toluene.
    Pawar SS; Mungikar AM
    Indian J Biochem Biophys; 1975 Jun; 12(2):133-5. PubMed ID: 1218876
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver.
    Steinberg P; Lafranconi WM; Wolf CR; Waxman DJ; Oesch F; Friedberg T
    Mol Pharmacol; 1987 Oct; 32(4):463-70. PubMed ID: 3670281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
    Kato Y; Kimura R
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug metabolism in cold-exposed animals.
    Gayathri AK; Rao MR; Padmanaban G
    Indian J Biochem Biophys; 1973 Mar; 10(1):31-3. PubMed ID: 4778113
    [No Abstract]   [Full Text] [Related]  

  • 26. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression of murine hepatic mixed function oxidase during infection with Listeria monocytogenes.
    Azri S; Renton KW
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1089-94. PubMed ID: 2447264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation of hepatic smooth and rough microsomes associated with drug-metabolizing enzymes.
    Gram TE
    Methods Enzymol; 1974; 31():225-37. PubMed ID: 4423643
    [No Abstract]   [Full Text] [Related]  

  • 29. Critical parameters for the determination of aminopyrine demethylase (ADP) activity, as assayed in hepatic microsomes from mice and rats [proceedings].
    Bauer C; Cercignani G; Gervasi PG; Stretti G; Turchi G; Di Natale G
    Ital J Biochem; 1976; 25(5):423-4. PubMed ID: 139385
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of hepatic microsomal drug-metabolizing enzymes by Habu snake (trimeresurus flavoviridis) venom fractions.
    Aniya Y; Matsusaki K
    Biochem Pharmacol; 1982 Jun; 31(11):2039-46. PubMed ID: 7115423
    [No Abstract]   [Full Text] [Related]  

  • 31. A new animal model for the study of cutaneous drug-metabolizing enzymes.
    Goerz G; Berger H; Tsambaos D
    Arch Dermatol Res; 1981; 270(3):367-9. PubMed ID: 6973956
    [No Abstract]   [Full Text] [Related]  

  • 32. Different changes on hepatic drug-metabolizing system caused by non-steroid anti-inflammatory drugs.
    Fracasso ME; Gasperini R; Leone R
    Acta Physiol Hung; 1990; 75 Suppl():109-10. PubMed ID: 2371835
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on liver toxicants: influence of bromobenzene on hepatic microsomal drug-metabolizing enzymes in the hamster.
    Mayer DG; Beyhl FE
    Toxicol Lett; 1983 Apr; 16(1-2):89-94. PubMed ID: 6836619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular organization and reconstitution of the hepatic microsomal monooxygenase system].
    Bachmanova GI; Kanaeva IP; Skotselias ED
    Vestn Akad Med Nauk SSSR; 1988; (1):43-52. PubMed ID: 3284229
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effects of nitrososarcosine on mouse liver mixed function oxidase activity.
    Friedman MA
    Experientia; 1974 Aug; 30(8):857-9. PubMed ID: 4413900
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-metabolizing enzyme activities in the liver and intestine of rats exposed to DDT: effects of vitamin A status.
    de Waziers I; Azaïs V
    Arch Environ Contam Toxicol; 1987 May; 16(3):343-8. PubMed ID: 3592760
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on ergothioneine. X. Effects of ergothioneine on the hepatic drug metabolizing enzyme system and on experimental hepatic injury in rats.
    Kawano H; Cho K; Haruna Y; Kawai Y; Mayumi T; Hama T
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1676-81. PubMed ID: 6616716
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical changes provoked in rat liver by cholestatic doses of -naphthylisothiocyanate.
    Buxton BH; Witschi H; Plaa GL
    Toxicol Appl Pharmacol; 1973 Jan; 24(1):60-72. PubMed ID: 4686786
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of dietary ascorbic acid supplementation on hepatic drug-metabolizing enzymes in the guinea pig.
    Sikic BI; Mimnaugh EG; Gram TE
    Biochem Pharmacol; 1977 Nov; 26(21):2037-41. PubMed ID: 411495
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphine-induced depression of the hepatic microsomal drug-metabolizing enzyme--effect on the lipid component.
    Amzel V; van der Hoeven TA
    Biochem Pharmacol; 1980 Feb; 29(4):658-61. PubMed ID: 7370057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.